Plain-English translation of NCT05743621 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called given together with , an approved prostate cancer drug. The goal is to find the right dose of the new medication that can be safely combined with , and to understand what side effects might occur. This is the first time these two drugs are being tested together in patients.
Men with advanced prostate cancer that has spread and stopped responding to hormone therapy need new treatment options. This trial is exploring whether adding this new medication to an existing approved drug might help these patients by working better than the approved drug alone.
You would first take alone for 28 days to allow it to reach a stable level in your body. Then you would start taking the new medication () by mouth along with the . Over time, your dose of the new medication may be increased to find the right level. You'll have blood tests, imaging scans, and tumor biopsies before and during treatment to monitor how you're responding and check for side effects.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States